(973) 276-1414

Blog

2015 KPRO Study Group Symposium April 14, 2015

2015 KPRO Study Group Symposium April 14, 2015
Attend a Lecture on the 4 Year results of the KeraKlear at the 2015 KPRO STUDY GROUP SYMPOSIUM  April 14, 2015, 3 PM, Located at the University of California, San Diego Shiley Eye Institute, 9415 Campus Point Drive, La Jolla, CA
Read more

New Patient Interview

New Patient Interview
Watch an interview of a Japanese cornea blind patient that achieved 20/20 vision with the KeraKlear artificial cornea. The patient underwent KeraKlear surgery by Kazuo Tsubota, MD, Chairman of Ophthalmology at Keio University, Tokyo, Japan. The KeraKlear is indicated for patients that have non-inflammatory forms of corneal blindness (e.g. keratoconus, corneal dystrophies, corneal scars, and corneal…
Read more

ESCRS 2013 Video

ESCRS 2013 Video
Dr. Yichieh Shiuey won 3rd Place at the 2013 ESCRS Video Awards in the Innovative Category. The KeraKlear is indicated for patients that have non-inflammatory forms of corneal blindness (e.g. keratoconus, corneal dystrophies, corneal scars, and corneal edema). The KeraKlear should not be used in patients with inflammatory causes of corneal blindness such as Steven’s…
Read more

Ziemer Ophthalmics AG

Ziemer Ophthalmics AG
Ziemer Ophthalmics AG is now the exclusive distributor for the KeraKlear artificial cornea in Germany, Austria and Switzerland. Ziemer has developed KeraKlear Software for its new Z6 Femtosecond Laser. This KeraKlear Software enables one-step bladeless implantation of the KeraKlear Artificial Cornea.  
Read more

Ziemer Ophthalmology becomes an exclusive distributor for KeraKlear

Ziemer Ophthalmic Systems AG is pleased to announce that it has obtained exclusive rights for distribution in Germany, Switzerland and Austria of the innovative KeraKlear artificial cornea and the EndoInjector from Keramed Inc., Sunnyvale, California . The KeraKlear Artificial Cornea is a medical device for the treatment of corneal blindness which can be implanted in…
Read more

Ophthalmology Times – Foldable intralamellar artificial cornea device lessens risk of graft failure

Foldable intralamellar artificial cornea device lessens risk of graft failure Early outcomes encouraging with use of foldable intralamellar artificial cornea By: Cheryl Guttman Krader - October 01, 2011 "Palo Alto, CA—Experience with a foldable intralamellar artificial cornea (KeraKlear, KeraMed) indicates it is a promising modality for visual rehabilitation in eyes at high risk for graft rejection…
Read more